BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 28271072)

  • 1. Impact of Physical Activity on Cognitive Decline, Dementia, and Its Subtypes: Meta-Analysis of Prospective Studies.
    Guure CB; Ibrahim NA; Adam MB; Said SM
    Biomed Res Int; 2017; 2017():9016924. PubMed ID: 28271072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of coronary heart disease on cognitive decline in Alzheimer's disease: a prospective longitudinal cohort study in primary care.
    Bleckwenn M; Kleineidam L; Wagner M; Jessen F; Weyerer S; Werle J; Wiese B; Lühmann D; Posselt T; König HH; Brettschneider C; Mösch E; Weeg D; Fuchs A; Pentzek M; Luck T; Riedel-Heller SG; Maier W; Scherer M
    Br J Gen Pract; 2017 Feb; 67(655):e111-e117. PubMed ID: 27993897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical activity as a protective factor for dementia and Alzheimer's disease: systematic review, meta-analysis and quality assessment of cohort and case-control studies.
    Iso-Markku P; Kujala UM; Knittle K; Polet J; Vuoksimaa E; Waller K
    Br J Sports Med; 2022 Jun; 56(12):701-709. PubMed ID: 35301183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical Activity Interventions in Preventing Cognitive Decline and Alzheimer-Type Dementia: A Systematic Review.
    Brasure M; Desai P; Davila H; Nelson VA; Calvert C; Jutkowitz E; Butler M; Fink HA; Ratner E; Hemmy LS; McCarten JR; Barclay TR; Kane RL
    Ann Intern Med; 2018 Jan; 168(1):30-38. PubMed ID: 29255839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline.
    Amieva H; Mokri H; Le Goff M; Meillon C; Jacqmin-Gadda H; Foubert-Samier A; Orgogozo JM; Stern Y; Dartigues JF
    Brain; 2014 Apr; 137(Pt 4):1167-75. PubMed ID: 24578544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Walking Pace and the Risk of Cognitive Decline and Dementia in Elderly Populations: A Meta-analysis of Prospective Cohort Studies.
    Quan M; Xun P; Chen C; Wen J; Wang Y; Wang R; Chen P; He K
    J Gerontol A Biol Sci Med Sci; 2017 Feb; 72(2):266-270. PubMed ID: 27927757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gait phenotype from mild cognitive impairment to moderate dementia: results from the GOOD initiative.
    Allali G; Annweiler C; Blumen HM; Callisaya ML; De Cock AM; Kressig RW; Srikanth V; Steinmetz JP; Verghese J; Beauchet O
    Eur J Neurol; 2016 Mar; 23(3):527-41. PubMed ID: 26662508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic risk of neurodegenerative diseases is associated with mild cognitive impairment and conversion to dementia.
    Adams HH; de Bruijn RF; Hofman A; Uitterlinden AG; van Duijn CM; Vernooij MW; Koudstaal PJ; Ikram MA
    Alzheimers Dement; 2015 Nov; 11(11):1277-85. PubMed ID: 25916564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms.
    Rouch L; Cestac P; Hanon O; Cool C; Helmer C; Bouhanick B; Chamontin B; Dartigues JF; Vellas B; Andrieu S
    CNS Drugs; 2015 Feb; 29(2):113-30. PubMed ID: 25700645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Habitual coffee consumption and risk of cognitive decline/dementia: A systematic review and meta-analysis of prospective cohort studies.
    Liu QP; Wu YF; Cheng HY; Xia T; Ding H; Wang H; Wang ZM; Xu Y
    Nutrition; 2016 Jun; 32(6):628-36. PubMed ID: 26944757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta-analysis of longitudinal studies.
    Chang-Quan H; Hui W; Chao-Min W; Zheng-Rong W; Jun-Wen G; Yong-Hong L; Yan-You L; Qing-Xiu L
    Int J Clin Pract; 2011 Dec; 65(12):1295-305. PubMed ID: 22093537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical activity, cognitive decline, and risk of dementia: 28 year follow-up of Whitehall II cohort study.
    Sabia S; Dugravot A; Dartigues JF; Abell J; Elbaz A; Kivimäki M; Singh-Manoux A
    BMJ; 2017 Jun; 357():j2709. PubMed ID: 28642251
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age at menopause and duration of reproductive period in association with dementia and cognitive function: A systematic review and meta-analysis.
    Georgakis MK; Kalogirou EI; Diamantaras AA; Daskalopoulou SS; Munro CA; Lyketsos CG; Skalkidou A; Petridou ET
    Psychoneuroendocrinology; 2016 Nov; 73():224-243. PubMed ID: 27543884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol, dementia and cognitive decline in the elderly: a systematic review.
    Peters R; Peters J; Warner J; Beckett N; Bulpitt C
    Age Ageing; 2008 Sep; 37(5):505-12. PubMed ID: 18487267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet and Alzheimer's disease risk factors or prevention: the current evidence.
    Solfrizzi V; Panza F; Frisardi V; Seripa D; Logroscino G; Imbimbo BP; Pilotto A
    Expert Rev Neurother; 2011 May; 11(5):677-708. PubMed ID: 21539488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Effects on Cognition in Randomized Controlled Trials.
    Ströhle A; Schmidt DK; Schultz F; Fricke N; Staden T; Hellweg R; Priller J; Rapp MA; Rieckmann N
    Am J Geriatr Psychiatry; 2015 Dec; 23(12):1234-1249. PubMed ID: 26601726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging.
    Solfrizzi V; Scafato E; Seripa D; Lozupone M; Imbimbo BP; D'Amato A; Tortelli R; Schilardi A; Galluzzo L; Gandin C; Baldereschi M; Di Carlo A; Inzitari D; Daniele A; Sabbà C; Logroscino G; Panza F;
    J Am Med Dir Assoc; 2017 Jan; 18(1):89.e1-89.e8. PubMed ID: 28012505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle-related factors in predementia and dementia syndromes.
    Solfrizzi V; Capurso C; D'Introno A; Colacicco AM; Santamato A; Ranieri M; Fiore P; Capurso A; Panza F
    Expert Rev Neurother; 2008 Jan; 8(1):133-58. PubMed ID: 18088206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.